Fundz

Aspargo Laboratories reported raising $290,000 in an initial SEC Form D filing, from an offering of $15 Million

PRIVATEDec 05, 2022$290K of $15M raised

Amount Raised

$290,000

$290,000 sold, per SEC Form D (first sale Nov 28, 2022)

Round Type

Seed

Englewood CliffsBiotechnologyHealthcare

Who to call at Aspargo Laboratories, and when

A new round usually means Aspargo Laboratories is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aspargo Laboratories raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aspargo Laboratories, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aspargo Laboratories. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aspargo Laboratories

Location

Englewood Cliffs, New Jersey, United States

About

Aspargo Labs, Inc. is a specialty pharmaceutical and MedTech company focused on converting the world’s most meaningful medications into liquid oral suspensions delivered via a proprietary, digitally connected device. Aspargo Labs’ suspension technology offers several key advantages, including improved absorption, ease of administration, flexible dosing, and improved patient adherence. Aspargo is leveraging its unique technology platform to transform a wide range of medications across various therapeutic areas. Aspargo’s initial focus is a liquid oral suspension formulation of sildenafil for the treatment of ED, which the Company markets in Europe and the United Kingdom.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aspargo Laboratories raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts9 people are listed at Aspargo Laboratories. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Aspargo Laboratories's next move

See what Strategic adds

Aspargo Laboratories raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.